Fischer Chemic Limited informed that the Board of Directors of Fischer Medical Ventures Limited (Formerly known as Fischer Chemic Limited) in its meeting held at the Registered Office of the Company on 04th May 2024 have inter-alia considered and approved the resignation of Mr. Dilip Suryakant Jha as the Director of the Company with effect from closure of Business hours on 04th May 2024 and he shall continue as the Chief Financial officer of the Company. On the recommendations of Nomination Remuneration Committee have approved the appointment of Mr. Shankar Varadharajan as the Chief Operating Officer with effect from 04th May 2024. Mr. Shankar is a seasoned global management expert with over three decades of extensive experience across diverse industries and geographies. Throughout his illustrious career, Mr. Shankar has held pivotal roles in renowned organizations, beginning from Industrial Development Bank of India (IDBI), where he honed his skills in investment banking, specializing in structuring and project financing for the telecom and power sectors. His contributions included spearheading key projects such as the Pennar
Aluminium merger with Hindalco and valuation of major power projects for industry giants like NTPC and Enron. Transitioning to the tech domain, Mr. Shankar made significant strides during his tenure at Motorola, USA, where he led various aspects of product development, deployment, and program management. His instrumental role in setting up CDMA system test labs in India and fostering a joint venture between Cisco and Motorola underscored his ability to drive innovation and collaboration. Joining the esteemed Tata Group further solidified Mr. Shankar's reputation as a strategic leader. At Tata Infotech Ltd, he spearheaded the expansion of software testing capabilities in the wireless domain, paving the way for enhanced service delivery. As Vice President at Tata Teleservices (Maharashtra) Limited, Mr. Shankar played a pivotal role in the company's turnaround strategy, guiding it towards profitability within a short timeframe. Venturing into the realm of investments, Mr. Shankar brought his wealth of experience to Broadcourt
Investments Ltd, where he managed a diverse portfolio exceeding USD 1 billion across real estate, agro industries, and stock markets. Driven by a passion for fostering innovation and entrepreneurship, Mr. Shankar embarked on a new chapter as an angel investor focus on the medtech and fintech sectors, where he actively nurtured and supported startups across India, Singapore, UAE, and the US. In every capacity, Mr. Shankar epitomizes leadership, innovation, and a relentless commitment to excellence. Venturing into the realm of investments, Mr. Shankar brought his wealth of experience to Broadcourt Investments Ltd, where he managed a diverse portfolio exceeding USD 1 billion across real estate, agro industries, and stock markets. Driven by a passion for fostering innovation and entrepreneurship, Mr. Shankar embarked on a new chapter as an angel investor focus on the medtech and fintech sectors, where he actively nurtured and supported startups across India, Singapore, UAE, and the US. In every capacity, Mr. Shankar epitomizes leadership, innovation, and a relentless commitment to excellence.